Table 4.
Publications on TAP block administration in laparoscopic IPOM VHR.
| Authors/Year/Country | Study design | Sample size n | Type of TAP block administration | Exclusion criteria | TAP block impact |
|---|---|---|---|---|---|
| Fields et al., /2015/USA | RCT | 100 (52 TAP-Block) | VG, intraoperative, BV 0.25% (50 ml) | Conversion to open Surgery | No significant difference in pain scores at 24 h postoperatively; reduced analgesic CNM |
| Sinha et al., /2018/India | Double blind RCT | 30 (15 TAP block) | UG, postoperativly, RV 0.375% (20 ml) | >ASA II stage | Reduced early postoperative pain (12 h*) |
| Jain et al., /2019/India | RCT | 50 (25 TAP block) | UG, preoperativly + port site infiltration RV 0.5% (10 ml) | >ASA II stage | Reduced early postoperative pain + CNM (12 h*) |
| Bhatia et al., /2019/India | Case series | 8 | UG, preoperatively RV 0,5% (5 ml) | >ASA II stage, large hernias, IH, UH | Median VAS score < 3 in 6/8 patients |
| Own results/2020/German | Matched pair analysis | 52 (26 TAP block) | VG, intraoperative, RV 0.375% (20 ml) | – | No impact* on pain + analgesic CNM |
BV bupivacaine; CNM cumulative need medication; IH incisional hernia.
PACU Postanaesthetic care unit; RV ropivacaine; TAP Transversus abdominis plane.
UG ultrasound-guided; UH umbilical hernia; VG visual guided; VHR Ventral hernia repair.
* Statistical significant.